H.R. 3537: Accelerating Access to Critical Therapies for ALS Act

CBO Score


Date of Report

Mon December 6th, 2021

Legislation Details

117th Congress

To direct the Secretary of Health and Human Services to support research on, and expanded access to, investigational drugs for amyotrophic lateral sclerosis, and for other purposes.

Sponsor: Rep. Michael Quigley — D — IL

Establishes grant programs to address neurodegenerative diseases, such as amyotrophic lateral sclerosis (also known as ALS or Lou Gehrig's disease), and contains other related provisions. The Department of Health and Human Services (HHS) shall award grants to eligible entities to facilitate patients' access to investigational drugs that diagnose or treat ALS. The Food and Drug Administration (FDA) shall award grants to public and...

View the full vote history of this bill on GovTrack.us.

As a registered user, you receive personalized updates to your inbox or dashboard when elected officials vote to spend more of your money. Choose to receive updates daily, weekly, monthly, or as they happen.


Sign up below to receive updates when your Members of Congress vote for new spending increases or cuts.

Lost your Password?

Don't be sad- we've got your back. Just enter your email below and instructions on resetting your password will be sent to you.

+ + HIGH LOW +
+ + HIGH LOW +